Search
Piclozotan
go.drugbank.com/drugs/DB12361InvestigationalPiclozotan has been investigated for the treatment of Parkinson's Disease.
Glyceryl Trierucate
go.drugbank.com/drugs/DB12528InvestigationalGlyceryl Trierucate has been investigated for the treatment of Adrenoleukodystrophy.
Cerlapirdine
go.drugbank.com/drugs/DB12229InvestigationalCerlapirdine has been investigated for the treatment of Alzheimer Disease.
FINLAY-FR-1
go.drugbank.com/drugs/DB16524ExperimentalFINLAY-FR-1, also known as Soberana 01, is a vaccine candidate for COVID-19 that is being led developmentally by the Finlay Vaccine Institute[L31373]. … clinical trial RPCEC00000332 (Phase I / II, randomized, controlled, adaptive, double-blind and multicenter study to evaluate the safety, reactogenicity and immunogenicity, of the prophylactic FINLAY-FR
Synonyms: FINLAY-FR-1 anti-SARS-CoV-2 vaccine candidateVamotinib
go.drugbank.com/drugs/DB15396InvestigationalVamotinib (PF-114) is under investigation in clinical trial NCT02885766 (Study to Evaluate Tolerability, Safety, Pharmacokinetics and Preliminary Efficacy of PF-114 for Oral Administration in Adults With … Ph+ Chronic Myeloid Leukemia, Which is Resistant to the 2-nd Generation Bcr-Abl Inhibitors or Has T315I Mutation in the BCR-ABL Gene).
KB002
go.drugbank.com/drugs/DB05194ExperimentalIt is developed for the treatment of autoimmune diseases, initially rheumatoid arthritis.
Senicapoc
go.drugbank.com/drugs/DB06280Investigational[A259068] It is being investigated for the treatment of sickle cell disease.
Baicalein
go.drugbank.com/drugs/DB16101InvestigationalBaicalein is under investigation in clinical trial NCT03830684 (A Randomized, Double-blind, Placebo-controlled, Multicenter and Phase ⅡA Clinical Trial for the Effectiveness and Safety of Baicalein Tablets
Categories: Compounds used in a research, industrial, or household settingCetuximab sarotalocan
go.drugbank.com/drugs/DB19240Investigational) for the treatment of Recurrent Head/Neck Cancer. … Cetuximab sarotalocan is under investigation in clinical trial NCT03769506 (ASP-1929 Photoimmunotherapy (PIT) Study in Recurrent Head/Neck Cancer for Patients Who Have Failed at Least Two Lines of Therapy
BL-1020
go.drugbank.com/drugs/DB05687InvestigationalBL-1020 is a first in class novel compound for the treatment of schizophrenia. It is being developed by BioLineRx (BioLine).